Fig. 3From: Colistin versus meropenem in the empirical treatment of ventilator-associated pneumonia (Magic Bullet study): an investigator-driven, open-label, randomized, noninferiority controlled triala Survival analysis to day 28 after randomization, the microbiologically modified intention-to-treat population. b Survival analysis to day 28 after randomization, the modified intention-to-treat populationBack to article page